Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
暂无分享,去创建一个
J. Spertus | D. Cohen | J. Valle | Mandeep Singh | Jae-Sik Jang | Kensey L. Gosch | Mohammed Qintar | A. Shafiq | R. Bach | D. Cohen | D. Cohen
[1] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[2] J. Spertus,et al. PREDICTING THE LIKELIHOOD FOR CORONARY ARTERY BYPASS GRAFTING IN NON ST ELEVATION MYOCARDIAL INFARCTION PATIENTS , 2015 .
[3] A. Jaffe,et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[4] Mandeep Singh,et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. , 2013, JACC. Cardiovascular interventions.
[5] Jeroen J. Bax,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .
[6] T. Lauer,et al. Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .
[7] Harlan M Krumholz,et al. Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): Design and Rationale of a Prospective Multicenter Registry , 2011, Circulation. Cardiovascular quality and outcomes.
[8] Michael A. Burke,et al. Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting. , 2011, American heart journal.
[9] I. Palacios,et al. Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry. , 2011, American heart journal.
[10] B. Dean,et al. Pattern of clopidogrel use in hospitalized patients receiving percutaneous coronary interventions. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[11] P. Gurbel,et al. Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery. , 2010, The Annals of thoracic surgery.
[12] R. Califf,et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.
[13] M. Cowen,et al. Is it possible to safely administer early a loading dose of clopidogrel before coronary angiography to patients who are candidates for percutaneous coronary intervention? , 2009, The American journal of cardiology.
[14] Deepak L. Bhatt,et al. Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. , 2009, American heart journal.
[15] H. Krumholz,et al. Financial barriers to health care and outcomes after acute myocardial infarction. , 2007, JAMA.
[16] Á. Avezum,et al. Predicting coronary artery bypass graft surgery in acute coronary syndromes. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[17] Basile Chaix,et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena , 2006, Journal of Epidemiology and Community Health.
[18] J. Spertus,et al. Effect of Difficulty Affording Health Care on Health Status After Coronary Revascularization , 2005, Circulation.
[19] G. Angelini,et al. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. , 2005, The Annals of thoracic surgery.
[20] Juan Merlo,et al. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. , 2005, American journal of epidemiology.
[21] E. de Marchena,et al. Development of a score to predict the need for coronary artery bypass graft surgery in patients with non-ST segment elevation acute coronary syndromes. , 2004, Annals of Thoracic Surgery.
[22] E. Braunwald,et al. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction. , 2004, Journal of the American College of Cardiology.
[23] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[24] Trevillore E. Raghunathan,et al. IVEware: Imputation and Variance Estimation Software User Guide , 2002 .
[25] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[26] S. Yusuf,et al. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. , 2000, European heart journal.
[27] Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. , 1998, The New England journal of medicine.
[28] Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. , 1998, The New England journal of medicine.
[29] D M Berwick,et al. Continuous improvement as an ideal in health care. , 1989, The New England journal of medicine.